<DOC>
	<DOCNO>NCT03063931</DOCNO>
	<brief_summary>In breast cancer patient undergo mastectomy , aim study evaluate magnesium administer 6 week start two week surgery induces decrease pain intensity one month post-mastectomy compare placebo group .</brief_summary>
	<brief_title>Pain Magnesium</brief_title>
	<detailed_description>This randomize , placebo-controlled double-blind clinical trial conduct Oncology Hospital , Clermont-Ferrand , France , 100 patient suffer breast cancer undergo total mastectomy . This clinical trial compare magnesium placebo prevention neuropathic pain induce mastectomy assess ( 0-10 ) numerical pain rating scale . Cognition , anxiety , depression , sleep quality life also assess .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Age â‰¥ 18 year , Patient breast cancer schedule total mastectomy without treatment two week inclusion without preoperative chemotherapy , Patient free new treatment diet time inclusion , Cooperation understand sufficient comply requirement study , Patients affiliate French Social Security , Patients free inform consent obtain Hypersensitivity active substance excipients Patient magnesemia &gt; 1,05 mmol/l Patient severe renal insufficiency creatinine clearance &lt; 30 ml min , Patient addiction alcohol , determine investigator , Diabetes ( type I II ) , Medical surgical history incompatible study , Patient receive treatment Quinidine , LDopa , Childbearing age , use effective contraceptive method , pregnancy lactation Patient exclusion period , total allowable compensation exceed Patients undergoing measure legal protection ( guardianship , supervision ... )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Mastectomy</keyword>
	<keyword>Pain</keyword>
	<keyword>Anxiety Depression</keyword>
	<keyword>Cognition</keyword>
	<keyword>Quality life</keyword>
</DOC>